SCHEMBL3342414

SCHEMBL3342414

CC1(C)CCCC(C)(C)N1C1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.37
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5698880 0.75 SIGMAR1 (0.31) SIGMAR1
SCHEMBL15921040 0.69 SIGMAR1 (0.33) SIGMAR1KDM4E
SCHEMBL19629143 0.69 SIGMAR1 (0.33) SIGMAR1
SCHEMBL10943620 0.68 SIGMAR1 (0.32) SIGMAR1KDM4EALDH1A1HSD17B10
SCHEMBL1232635 0.67 ACHE (0.32) ALDH1A1
SCHEMBL8708442 0.65 ADH1C (0.31)
SCHEMBL19987632 0.65 SIGMAR1 (0.34) SIGMAR1
SCHEMBL10349834 0.65 ALDH1A1 (0.32) ALDH1A1HSD17B10
SCHEMBL11188498 0.65 SIGMAR1 (0.31) SIGMAR1
SCHEMBL8361086 0.65 ALDH1A1 (0.35) SIGMAR1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11738487-B2 Processes for making molded flexible foams and flexible foams produced thereby COVESTRO LLC (US) 2023-08-29 US disclosed
CN-114805727-A Process for preparing molded flexible foams and flexible foams prepared therefrom 科思创有限公司 2022-07-29 CN disclosed
US-20220235168-A1 PROCESSES FOR MAKING MOLDED FLEXIBLE FOAMS AND FLEXIBLE FOAMS PRODUCED THEREBY COVESTRO LLC 2022-07-28 US disclosed
US-20220234262-A1 PROCESSES FOR MAKING MOLDED FLEXIBLE FOAMS AND FLEXIBLE FOAMS PRODUCED THEREBY COVESTRO LLC 2022-07-28 US disclosed
EP-4032926-A1 PROCESSES FOR MAKING MOLDED FLEXIBLE FOAMS AND FLEXIBLE FOAMS PRODUCED THEREBY Covestro LLC (US) 2022-07-27 EP disclosed
EP-4032925-A1 PROCESSES FOR MAKING MOLDED FLEXIBLE FOAMS AND FLEXIBLE FOAMS PRODUCED THEREBY Covestro LLC (US) 2022-07-27 EP disclosed
CN-114773561-A Process for producing molded flexible foam and flexible foam produced by the process 科思创有限公司 2022-07-22 CN disclosed
US-8362254-B2 Method for the production of 4-formylaminopiperidine derivatives BASF SE (DE) 2013-01-29 US disclosed
CN-101797457-A Air filtration material TORAY FIBER RES INST CN CO LTD 2010-08-11 CN disclosed
US-20100160637-A1 METHOD FOR THE PRODUCTION OF 4-FORMYLAMINOPIPERIDINE DERIVATIVES BASF SE (DE) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160637-A1 METHOD FOR THE PRODUCTION OF 4-FORMYLAMINOPIPERIDINE DERIVATIVES UMPS, PAH, DPYD SIGMAR1 2406/4885KDM4E 1746/4885ALDH1A1 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.